| Mar 26 | Mar 25 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 11.51M | $ 11.69M | $ 9.76M | $ 11.96M | $ 4.33M |
| Gross Profit | $ 7.74M | $ 9.73M | $ 7.72M | $ 9.94M | $ 2.00M |
| Operating Income | $ -45.11M | $ -30.83M | $ -34.29M | $ -34.41M | $ -40.71M |
| EBITDA | $ -51.73M | $ -36.66M | $ -32.76M | $ -33.38M | $ -42.37M |
| Net Income | $ -53.43M | $ -38.49M | $ -41.30M | $ -47.45M | $ -52.59M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 968.00K | $ 8.00M | $ 6.47M | $ 5.47M | $ 17.05M |
| Total Assets | $ 38.32M | $ 53.42M | $ 50.76M | $ 47.45M | $ 53.27M |
| Total Debt | $ 43.61M | $ 36.53M | $ 37.09M | $ 34.84M | $ 29.36M |
| Net Debt | $ 42.64M | $ 28.52M | $ 30.63M | $ 29.37M | $ 12.31M |
| Total Liabilities | $ 57.01M | $ 46.93M | $ 45.87M | $ 48.81M | $ 41.41M |
| Stockholders' Equity | $ -17.29M | $ 7.29M | $ 4.96M | $ -657.00K | $ 11.61M |
| Cash Flow | |||||
| Free Cash Flow | $ 5.77M | $ -29.61M | $ -33.24M | $ -34.78M | $ -34.98M |
| Operating Cash Flow | $ 5.80M | $ -29.38M | $ -33.24M | $ -33.10M | $ -34.97M |
| Investing Cash Flow | $ 149.00K | $ -231.00K | $ 0.00 | $ -1.68M | $ -6.00K |
| Financing Cash Flow | $ -44.33M | $ 31.20M | $ 34.23M | $ 23.18M | $ 43.94M |
Jaguar Animal Health (DE:1JA1)
FRANKFURT:1JA1
